𝛼SK or Search

ENTITY

Sam Chun Dang Pharm (000250 KS)

31

Analysis

Health Care • South Korea

Sam Chun Dang Pharm Co., Ltd. (SCD) develops, manufactures, and markets medicines for human health care. The Company specializes in producing medical treatment drugs as well as diagnostic drugs. SCD Pharm's products include antibiotics, respiratory stimulants, pneumonia diagnosis devices, and many others.

more

Refresh

Exchange Announcement • 06 Aug 2026 13:57

[Revised] Material Management Information related to Judgment of Investment(IND Approval Determination)

Exchange Announcement • 05 Aug 2026 17:15

[Revised] Material Management Information related to Judgment of Investment(IND Approval Determination)(ì 1í ë¹ë¨ë³ íìë¥¼ ëìì¼ë¡ ì ìíë¹ í´ë¨í ì¡°ê±´ ë° ìì´ ìì·¨ í, ê²½êµ¬ì© ì¸ìë¦° SCD0503ê³¼ í¼í í¬ì¬ ì¸ìë¦° ê°ì ìëì ìì²´ì´ì©ë¥ , ìëì ìë¬¼íì í¨ë ¥ ë° ìì ìí¥ íê°ë¥¼ ìí ìììí)

Exchange Announcement • 05 Aug 2026 17:15

[Revised] Material Management Information related to Judgment of Investment(Application for IND Approval)(ì 1í ë¹ë¨ë³ íìë¥¼ ëìì¼ë¡ ì ìíë¹ í´ë¨í ì¡°ê±´ ë° ìì´ ìì·¨ í, ê²½êµ¬ì© ì¸ìë¦° SCD0503ê³¼ í¼í í¬ì¬ ì¸ìë¦° ê°ì ìëì ìì²´ì´ì©ë¥ , ìëì ìë¬¼íì í¨ë ¥ ë° ìì ìí¥ íê°ë¥¼ ìí ìììí)

Exchange Announcement • 22 Jul 2026 20:01

Extension of overheated short-selling issue designation (subject to extension of restriction on short-selling)

Exchange Announcement • 21 Jul 2026 20:01

Designation of overheated short-selling issues (applied by a restriction on short-selling)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x